Updated: January 17, 2026
Alternatives to Tranylcypromine If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- Why Switching From Tranylcypromine Is Complicated
- Option 1: Phenelzine (Nardil) — The Closest MAOI Alternative
- Option 2: Isocarboxazid (Marplan) — Another MAOI Option
- Option 3: Selegiline Transdermal (Emsam) — A Newer MAOI Delivery Option
- What About SSRIs, SNRIs, or Other Antidepressants?
- What to Do Right Now If You Can't Fill Tranylcypromine
If you can't fill your tranylcypromine prescription, there are other MAOIs and antidepressants to discuss with your doctor. Here's what patients need to know in 2026.
Tranylcypromine (Parnate) is a specialized medication used for treatment-resistant depression, and the patients who take it have typically already tried many other options. That makes the stakes higher when availability becomes a problem: you can't simply swap it for any antidepressant off the shelf.
Important: Never stop tranylcypromine or switch medications without guidance from your prescriber. MAOIs have serious interactions and washout requirements. This article provides educational information about alternatives — your doctor must determine what, if any, is right for you.
Why Switching From Tranylcypromine Is Complicated
Tranylcypromine irreversibly inhibits monoamine oxidase enzymes, and MAO activity takes up to 10 days to return to normal after stopping the drug. This means that before starting most other antidepressants — especially SSRIs, SNRIs, or TCAs — you must wait at least 14 days after your last dose of tranylcypromine. If you were on fluoxetine before starting tranylcypromine, you had to wait 5 weeks for fluoxetine to clear your system first.
This washout period is non-negotiable from a safety standpoint. Combining an MAOI with serotonergic drugs can cause serotonin syndrome — a potentially life-threatening emergency. This is why any transition must be carefully managed by your physician or psychiatrist.
Option 1: Phenelzine (Nardil) — The Closest MAOI Alternative
Phenelzine (Nardil) is another irreversible, nonselective MAOI that is FDA-approved for major depressive disorder. It works through a similar mechanism to tranylcypromine — blocking MAO-A and MAO-B — and carries the same dietary restrictions (avoid high-tyramine foods) and drug interaction warnings.
Key differences to discuss with your doctor:
Phenelzine comes in 15 mg tablets (vs. 10 mg for tranylcypromine) and is dosed up to 90 mg/day
Phenelzine is a hydrazine derivative, carrying a slightly higher risk of hepatotoxicity than tranylcypromine
Some patients report more weight gain with phenelzine; tranylcypromine is generally weight-neutral
There must be at least a 1-week washout between stopping one MAOI and starting another
Generic phenelzine is available and may be easier to find at some pharmacies, though it also has its own availability challenges at chain pharmacies.
Option 2: Isocarboxazid (Marplan) — Another MAOI Option
Isocarboxazid (Marplan) is the least commonly prescribed of the three classical antidepressant MAOIs. It comes in 10 mg tablets and can be dosed up to 60 mg/day. Like phenelzine, it is a hydrazine-class MAOI with the same dietary restrictions and drug interaction profile. Some patients who tolerate tranylcypromine may also tolerate isocarboxazid, but clinical experience with it is more limited.
Option 3: Selegiline Transdermal (Emsam) — A Newer MAOI Delivery Option
Selegiline transdermal (Emsam) is an MAOI delivered through a skin patch rather than an oral tablet. It is FDA-approved for major depressive disorder. At its lowest dose (6 mg/24 hours), the Emsam patch does not require the full tyramine dietary restrictions — a significant advantage over oral MAOIs like tranylcypromine. Higher doses (9 mg and 12 mg) do require dietary restrictions.
Emsam is significantly more expensive than generic tranylcypromine and may require prior authorization from your insurance. However, for patients who benefited from an MAOI and cannot access tranylcypromine, it is worth a conversation with your prescriber.
What About SSRIs, SNRIs, or Other Antidepressants?
Most patients on tranylcypromine have already tried SSRIs and SNRIs without adequate response — that's typically how they ended up on an MAOI in the first place. However, if your clinical situation has changed, or if a very long washout period is acceptable in your case, medications such as venlafaxine (Effexor XR), duloxetine, or bupropion may be revisited — but only after the appropriate washout period (at least 14 days after stopping tranylcypromine).
Your doctor may also consider adjunctive treatments such as lithium augmentation, atypical antipsychotics like aripiprazole or quetiapine, or referral for transcranial magnetic stimulation (TMS) or electroconvulsive therapy (ECT) if depression is severe and medication access is genuinely compromised.
What to Do Right Now If You Can't Fill Tranylcypromine
Before giving up on finding tranylcypromine, exhaust these options:
Use medfinder to check pharmacies near you that have it in stock
Ask your pharmacy to place a special order (usually arrives within 1-2 business days)
Ask your prescriber about bridge supplies or samples while you wait
Check hospital outpatient and independent pharmacies, which may carry it when chains don't
For a full step-by-step approach, see: How to Find Tranylcypromine in Stock Near You (Tools + Tips).
If cost is part of the challenge, see our guide: How to Save Money on Tranylcypromine in 2026.
Frequently Asked Questions
Phenelzine (Nardil) is the most pharmacologically similar alternative — both are irreversible, nonselective MAOIs. Isocarboxazid (Marplan) is another option in the same class. All three require the same dietary restrictions (avoiding high-tyramine foods) and have similar drug interaction profiles. Your psychiatrist can advise which is most appropriate for your situation.
No. You must wait at least 14 days after stopping tranylcypromine before starting an SSRI, SNRI, or TCA. This washout period is necessary because MAO inhibition can persist up to 10 days after stopping tranylcypromine, and combining these drugs risks life-threatening serotonin syndrome. Only switch under the direct supervision of your prescriber.
Selegiline transdermal (Emsam) is FDA-approved for major depressive disorder and at its lowest dose (6 mg patch) does not require the strict tyramine dietary restrictions needed with oral MAOIs. However, it is more expensive than generic tranylcypromine and often requires insurance prior authorization. It is worth discussing with your prescriber if tranylcypromine is unavailable long-term.
At least 1 week (7 days) should elapse between stopping tranylcypromine and starting another MAOI such as phenelzine or isocarboxazid. This allows MAO inhibition to sufficiently recover before introducing another MAOI. Your doctor will determine the exact timeline based on your dosage and clinical situation.
Generic tranylcypromine is often the most affordable MAOI option — as low as $67-$75 with discount cards like GoodRx or SingleCare. If cost is a barrier, NeedyMeds.org lists patient assistance programs. Your prescriber can also help navigate insurance coverage, including writing a prior authorization letter documenting treatment-resistant depression.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Tranylcypromine also looked for:
More about Tranylcypromine
35,233 have already found their meds with Medfinder.
Start your search today.





